Pre-order Enquiry
Request Free Sample
Global Radiopharmaceuticals in Nuclear Medical Market Research Report 2021
SKU ID : QYR-17094297 | Publishing Date : 05-Jan-2021 | No. of pages : 124
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Radiopharmaceuticals in Nuclear Medical Market Research Report 2021
1 Radiopharmaceuticals in Nuclear Medical Market Overview1.1 Product Overview and Scope of Radiopharmaceuticals in Nuclear Medical
1.2 Radiopharmaceuticals in Nuclear Medical Segment by Type
1.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapy Radiopharmaceuticals
1.2.4 Enriched Stable Isotopes
1.3 Radiopharmaceuticals in Nuclear Medical Segment by Application
1.3.1 Radiopharmaceuticals in Nuclear Medical Sales Comparison by Application: (2021-2027)
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Industrial
1.4 Global Radiopharmaceuticals in Nuclear Medical Market Size Estimates and Forecasts
1.4.1 Global Radiopharmaceuticals in Nuclear Medical Revenue 2016-2027
1.4.2 Global Radiopharmaceuticals in Nuclear Medical Sales 2016-2027
1.4.3 Radiopharmaceuticals in Nuclear Medical Market Size by Region: 2016 Versus 2021 Versus 2027
2 Radiopharmaceuticals in Nuclear Medical Market Competition by Manufacturers
2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Manufacturers (2016-2021)
2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Radiopharmaceuticals in Nuclear Medical Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Radiopharmaceuticals in Nuclear Medical Manufacturing Sites, Area Served, Product Type
2.5 Radiopharmaceuticals in Nuclear Medical Market Competitive Situation and Trends
2.5.1 Radiopharmaceuticals in Nuclear Medical Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Radiopharmaceuticals in Nuclear Medical Players Market Share by Revenue
2.5.3 Global Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Radiopharmaceuticals in Nuclear Medical Retrospective Market Scenario by Region
3.1 Global Radiopharmaceuticals in Nuclear Medical Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Radiopharmaceuticals in Nuclear Medical Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Country
3.3.1 North America Radiopharmaceuticals in Nuclear Medical Sales by Country
3.3.2 North America Radiopharmaceuticals in Nuclear Medical Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Country
3.4.1 Europe Radiopharmaceuticals in Nuclear Medical Sales by Country
3.4.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Region
3.5.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by Region
3.5.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Country
3.6.1 Latin America Radiopharmaceuticals in Nuclear Medical Sales by Country
3.6.2 Latin America Radiopharmaceuticals in Nuclear Medical Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Country
3.7.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by Country
3.7.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Radiopharmaceuticals in Nuclear Medical Historic Market Analysis by Type
4.1 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2016-2021)
4.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type (2016-2021)
4.3 Global Radiopharmaceuticals in Nuclear Medical Price by Type (2016-2021)
5 Global Radiopharmaceuticals in Nuclear Medical Historic Market Analysis by Application
5.1 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2016-2021)
5.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Application (2016-2021)
5.3 Global Radiopharmaceuticals in Nuclear Medical Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Bracco Imaging
6.1.1 Bracco Imaging Corporation Information
6.1.2 Bracco Imaging Description and Business Overview
6.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bracco Imaging Product Portfolio
6.1.5 Bracco Imaging Recent Developments/Updates
6.2 Cambridge Isotope Laboratories
6.2.1 Cambridge Isotope Laboratories Corporation Information
6.2.2 Cambridge Isotope Laboratories Description and Business Overview
6.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Cambridge Isotope Laboratories Product Portfolio
6.2.5 Cambridge Isotope Laboratories Recent Developments/Updates
6.3 Cardinal Health
6.3.1 Cardinal Health Corporation Information
6.3.2 Cardinal Health Description and Business Overview
6.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Cardinal Health Product Portfolio
6.3.5 Cardinal Health Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Corporation Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Medtronic Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 Eczacibasi-Monrol
6.5.1 Eczacibasi-Monrol Corporation Information
6.5.2 Eczacibasi-Monrol Description and Business Overview
6.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Eczacibasi-Monrol Product Portfolio
6.5.5 Eczacibasi-Monrol Recent Developments/Updates
6.6 Fujifilm Holdings Corporation
6.6.1 Fujifilm Holdings Corporation Corporation Information
6.6.2 Fujifilm Holdings Corporation Description and Business Overview
6.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Fujifilm Holdings Corporation Product Portfolio
6.6.5 Fujifilm Holdings Corporation Recent Developments/Updates
6.7 GE Healthcare (Subsidiary Of General Electric Company)
6.6.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
6.6.2 GE Healthcare (Subsidiary Of General Electric Company) Description and Business Overview
6.6.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GE Healthcare (Subsidiary Of General Electric Company) Product Portfolio
6.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Developments/Updates
6.8 IBA Group
6.8.1 IBA Group Corporation Information
6.8.2 IBA Group Description and Business Overview
6.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.8.4 IBA Group Product Portfolio
6.8.5 IBA Group Recent Developments/Updates
6.9 Lantheus Medical Imaging
6.9.1 Lantheus Medical Imaging Corporation Information
6.9.2 Lantheus Medical Imaging Description and Business Overview
6.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Lantheus Medical Imaging Product Portfolio
6.9.5 Lantheus Medical Imaging Recent Developments/Updates
6.10 Nordion
6.10.1 Nordion Corporation Information
6.10.2 Nordion Description and Business Overview
6.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Nordion Product Portfolio
6.10.5 Nordion Recent Developments/Updates
6.11 Ntp Radioisotopes
6.11.1 Ntp Radioisotopes Corporation Information
6.11.2 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Description and Business Overview
6.11.3 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Ntp Radioisotopes Product Portfolio
6.11.5 Ntp Radioisotopes Recent Developments/Updates
6.12 Siemens Healthcare
6.12.1 Siemens Healthcare Corporation Information
6.12.2 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Description and Business Overview
6.12.3 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Siemens Healthcare Product Portfolio
6.12.5 Siemens Healthcare Recent Developments/Updates
6.13 Taiyo Nippon Sanso Corporation
6.13.1 Taiyo Nippon Sanso Corporation Corporation Information
6.13.2 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Description and Business Overview
6.13.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Taiyo Nippon Sanso Corporation Product Portfolio
6.13.5 Taiyo Nippon Sanso Corporation Recent Developments/Updates
6.14 Urenco Limited
6.14.1 Urenco Limited Corporation Information
6.14.2 Urenco Limited Radiopharmaceuticals in Nuclear Medical Description and Business Overview
6.14.3 Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Urenco Limited Product Portfolio
6.14.5 Urenco Limited Recent Developments/Updates
6.15 Rotem Industries
6.15.1 Rotem Industries Corporation Information
6.15.2 Rotem Industries Radiopharmaceuticals in Nuclear Medical Description and Business Overview
6.15.3 Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Rotem Industries Product Portfolio
6.15.5 Rotem Industries Recent Developments/Updates
7 Radiopharmaceuticals in Nuclear Medical Manufacturing Cost Analysis
7.1 Radiopharmaceuticals in Nuclear Medical Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
7.4 Radiopharmaceuticals in Nuclear Medical Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Radiopharmaceuticals in Nuclear Medical Distributors List
8.3 Radiopharmaceuticals in Nuclear Medical Customers
9 Radiopharmaceuticals in Nuclear Medical Market Dynamics
9.1 Radiopharmaceuticals in Nuclear Medical Industry Trends
9.2 Radiopharmaceuticals in Nuclear Medical Growth Drivers
9.3 Radiopharmaceuticals in Nuclear Medical Market Challenges
9.4 Radiopharmaceuticals in Nuclear Medical Market Restraints
10 Global Market Forecast
10.1 Radiopharmaceuticals in Nuclear Medical Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Radiopharmaceuticals in Nuclear Medical by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Radiopharmaceuticals in Nuclear Medical by Type (2022-2027)
10.2 Radiopharmaceuticals in Nuclear Medical Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Radiopharmaceuticals in Nuclear Medical by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Radiopharmaceuticals in Nuclear Medical by Application (2022-2027)
10.3 Radiopharmaceuticals in Nuclear Medical Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Radiopharmaceuticals in Nuclear Medical by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Radiopharmaceuticals in Nuclear Medical by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Radiopharmaceuticals in Nuclear Medical Market Research Report 2021
List of TablesTable 1. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Radiopharmaceuticals in Nuclear Medical Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Radiopharmaceuticals in Nuclear Medical Covered in This Study
Table 5. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Radiopharmaceuticals in Nuclear Medical Sales Share by Manufacturers (2016-2021)
Table 7. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Radiopharmaceuticals in Nuclear Medical Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Radiopharmaceuticals in Nuclear Medical Manufacturing Sites and Area Served
Table 11. Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
Table 12. Global Radiopharmaceuticals in Nuclear Medical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Radiopharmaceuticals in Nuclear Medical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceuticals in Nuclear Medical as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Radiopharmaceuticals in Nuclear Medical Sales by Region (2016-2021) & (K MT)
Table 16. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2016-2021)
Table 17. Global Radiopharmaceuticals in Nuclear Medical Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Radiopharmaceuticals in Nuclear Medical Sales by Country (2016-2021) & (K MT)
Table 19. North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country (2016-2021)
Table 20. North America Radiopharmaceuticals in Nuclear Medical Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country (2016-2021)
Table 22. Europe Radiopharmaceuticals in Nuclear Medical Sales by Country (2016-2021) & (K MT)
Table 23. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country (2016-2021)
Table 24. Europe Radiopharmaceuticals in Nuclear Medical Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region (2016-2021)
Table 30. Latin America Radiopharmaceuticals in Nuclear Medical Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country (2016-2021)
Table 32. Latin America Radiopharmaceuticals in Nuclear Medical Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country (2016-2021)
Table 38. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Type (2016-2021)
Table 39. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2016-2021)
Table 40. Global Radiopharmaceuticals in Nuclear Medical Revenue (Million US$) by Type (2016-2021)
Table 41. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Type (2016-2021)
Table 42. Global Radiopharmaceuticals in Nuclear Medical Price (USD/MT) by Type (2016-2021)
Table 43. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Application (2016-2021)
Table 44. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2016-2021)
Table 45. Global Radiopharmaceuticals in Nuclear Medical Revenue (Million US$) by Application (2016-2021)
Table 46. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Application (2016-2021)
Table 47. Global Radiopharmaceuticals in Nuclear Medical Price (USD/MT) by Application (2016-2021)
Table 48. Bracco Imaging Corporation Information
Table 49. Bracco Imaging Description and Business Overview
Table 50. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product
Table 52. Bracco Imaging Recent Developments/Updates
Table 53. Cambridge Isotope Laboratories Corporation Information
Table 54. Cambridge Isotope Laboratories Description and Business Overview
Table 55. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product
Table 57. Cambridge Isotope Laboratories Recent Developments/Updates
Table 58. Cardinal Health Corporation Information
Table 59. Cardinal Health Description and Business Overview
Table 60. Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Cardinal Health Radiopharmaceuticals in Nuclear Medical Product
Table 62. Cardinal Health Recent Developments/Updates
Table 63. Medtronic Corporation Information
Table 64. Medtronic Description and Business Overview
Table 65. Medtronic Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Medtronic Radiopharmaceuticals in Nuclear Medical Product
Table 67. Medtronic Recent Developments/Updates
Table 68. Eczacibasi-Monrol Corporation Information
Table 69. Eczacibasi-Monrol Description and Business Overview
Table 70. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product
Table 72. Eczacibasi-Monrol Recent Developments/Updates
Table 73. Fujifilm Holdings Corporation Corporation Information
Table 74. Fujifilm Holdings Corporation Description and Business Overview
Table 75. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product
Table 77. Fujifilm Holdings Corporation Recent Developments/Updates
Table 78. GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
Table 79. GE Healthcare (Subsidiary Of General Electric Company) Description and Business Overview
Table 80. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product
Table 82. GE Healthcare (Subsidiary Of General Electric Company) Recent Developments/Updates
Table 83. IBA Group Corporation Information
Table 84. IBA Group Description and Business Overview
Table 85. IBA Group Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. IBA Group Radiopharmaceuticals in Nuclear Medical Product
Table 87. IBA Group Recent Developments/Updates
Table 88. Lantheus Medical Imaging Corporation Information
Table 89. Lantheus Medical Imaging Description and Business Overview
Table 90. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product
Table 92. Lantheus Medical Imaging Recent Developments/Updates
Table 93. Nordion Corporation Information
Table 94. Nordion Description and Business Overview
Table 95. Nordion Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Nordion Radiopharmaceuticals in Nuclear Medical Product
Table 97. Nordion Recent Developments/Updates
Table 98. Ntp Radioisotopes Corporation Information
Table 99. Ntp Radioisotopes Description and Business Overview
Table 100. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product
Table 102. Ntp Radioisotopes Recent Developments/Updates
Table 103. Siemens Healthcare Corporation Information
Table 104. Siemens Healthcare Description and Business Overview
Table 105. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product
Table 107. Siemens Healthcare Recent Developments/Updates
Table 108. Taiyo Nippon Sanso Corporation Corporation Information
Table 109. Taiyo Nippon Sanso Corporation Description and Business Overview
Table 110. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product
Table 112. Taiyo Nippon Sanso Corporation Recent Developments/Updates
Table 113. Urenco Limited Corporation Information
Table 114. Urenco Limited Description and Business Overview
Table 115. Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 116. Urenco Limited Radiopharmaceuticals in Nuclear Medical Product
Table 117. Urenco Limited Recent Developments/Updates
Table 118. Rotem Industries Corporation Information
Table 119. Rotem Industries Description and Business Overview
Table 120. Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 121. Rotem Industries Radiopharmaceuticals in Nuclear Medical Product
Table 122. Rotem Industries Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Radiopharmaceuticals in Nuclear Medical Distributors List
Table 126. Radiopharmaceuticals in Nuclear Medical Customers List
Table 127. Radiopharmaceuticals in Nuclear Medical Market Trends
Table 128. Radiopharmaceuticals in Nuclear Medical Growth Drivers
Table 129. Radiopharmaceuticals in Nuclear Medical Market Restraints
Table 130. Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Type (2022-2027) & (K MT)
Table 131. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by Type (2022-2027)
Table 132. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 133. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Type (2022-2027)
Table 134. Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Application (2022-2027) & (K MT)
Table 135. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by Application (2022-2027)
Table 136. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 137. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Application (2022-2027)
Table 138. Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Region (2022-2027) & (K MT)
Table 139. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by Region (2022-2027)
Table 140. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 141. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Region (2022-2027)
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Radiopharmaceuticals in Nuclear Medical
Figure 2. Global Radiopharmaceuticals in Nuclear Medical Market Share by Type in 2020 & 2027
Figure 3. Diagnostic Radiopharmaceuticals Product Picture
Figure 4. Therapy Radiopharmaceuticals Product Picture
Figure 5. Enriched Stable Isotopes Product Picture
Figure 6. Global Radiopharmaceuticals in Nuclear Medical Market Share by Application in 2020 & 2027
Figure 7. Diagnostic Application
Figure 8. Therapeutic Application
Figure 9. Research
Figure 10. Pharmaceutical
Figure 11. Industrial
Figure 12. Global Radiopharmaceuticals in Nuclear Medical Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Radiopharmaceuticals in Nuclear Medical Market Size 2016-2027 (US$ Million)
Figure 14. Global Radiopharmaceuticals in Nuclear Medical Sales 2016-2027 (K MT)
Figure 15. Global Radiopharmaceuticals in Nuclear Medical Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Radiopharmaceuticals in Nuclear Medical Sales Share by Manufacturers in 2020
Figure 17. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Radiopharmaceuticals in Nuclear Medical Players: Market Share by Revenue in 2020
Figure 19. Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2016-2021)
Figure 21. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region in 2020
Figure 22. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region (2016-2021)
Figure 23. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region in 2020
Figure 24. U.S. Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Radiopharmaceuticals in Nuclear Medical by Type (2016-2021)
Figure 49. Sales Market Share of Radiopharmaceuticals in Nuclear Medical by Application (2016-2021)
Figure 50. Sales Market Share of Radiopharmaceuticals in Nuclear Medical by Application in 2020
Figure 51. Revenue Share of Radiopharmaceuticals in Nuclear Medical by Application (2016-2021)
Figure 52. Revenue Share of Radiopharmaceuticals in Nuclear Medical by Application in 2020
Figure 53. Manufacturing Cost Structure of Radiopharmaceuticals in Nuclear Medical
Figure 54. Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
Figure 55. Radiopharmaceuticals in Nuclear Medical Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Keyplayers in Global Radiopharmaceuticals in Nuclear Medical Market Research Report 2021
Bracco ImagingCambridge Isotope Laboratories
Cardinal Health
Medtronic
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Lantheus Medical Imaging
Nordion
Ntp Radioisotopes
Siemens Healthcare
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries
